Cannabis Sector Policy Wins and Q4 Signals - Mar 14

The Big Picture

Virginia moving a legalization bill to the governor's desk and Georgia passing medical cannabis expansion measures were the biggest developments for the cannabis sector this weekend. These state-level policy wins improve the legislative backdrop for operators and patients, and they could meaningfully expand addressable markets in coming years.

At the company level, Ascend Wellness's fourth-quarter report showed growth and margin improvement despite a higher operating loss, reinforcing the recurring theme that regulated operators are continuing to scale and tighten operations. What does this mean for you as an investor? It means policy momentum and operational execution are aligning, at least regionally, which could support selective names heading into Monday.

Market Highlights

U.S. equity markets were closed on Saturday; the last trading session was Friday, March 13 and the next session opens Monday, March 16. Below are the quick facts and company-level highlights investors should note heading into the long weekend.

• Virginia legalization: State House and Senate sent companion bills to the governor, creating a fast path for recreational sales if the governor signs the package.
• Georgia medical expansion: The Georgia House approved measures to add qualifying conditions and expand consumption methods, a bipartisan move that could broaden patient access.
• Oklahoma workplace protections: Lawmakers rejected a measure that would have allowed employers more leeway to fire medical marijuana users, a win for patient and worker protections.
• Ascend Wellness Holdings ($AAWH): Reported Q4 2025 revenue of $120.5 million and full-year 2025 revenue of $500.6 million, with adjusted EBITDA margin expanding to 25.1% in Q4 and 23.4% for the full year. The company finished with $85.7 million in cash and said its retail footprint reached 48 locations.
• Tennessee enforcement: Regulators found more than 650 shops selling unlicensed hemp-derived THC products, signaling tougher compliance scrutiny for the market.
• Names to watch heading into Monday include sector favorites and ETFs such as $MSOS, $TCNNF, $GTBIF, $CURLF, and $TLRY for portfolio exposure and liquidity.

Key Developments

Virginia Legalization Advances to Governor

Both chambers of the Virginia legislature approved a final bill to legalize recreational marijuana sales and sent it to the governor's desk. The measures had to be reconciled during the session, but lawmakers ultimately aligned companion bills and approved a final package late on March 13.

For investors, a signed bill would open a new regulated retail market in a populous state. Expect licensing timelines, tax structures, and distribution rules to matter most for which operators win market share. Do you own names with operations or partners ready to enter Virginia? If not, this is a time to assess potential entry points.

Georgia Expands Medical Program, Bipartisan Backing

The Georgia House passed a package of reforms to modernize the state's medical cannabis program, adding qualifying conditions and allowing expanded consumption methods for adults 21 and older, including regulated vaping for certain patients. The vote had broad bipartisan support, underscoring growing legislative consensus on patient access.

This kind of incremental expansion often translates into steady market growth rather than a one-off spike. Companies with distribution partnerships or potential license pathways in Georgia could see long-term demand gains as the program scales.

Oklahoma Vote and Tennessee Enforcement Highlight Regulatory Balance

Oklahoma lawmakers defeated a bill that would have permitted employers more flexibility to fire medical marijuana users. The sponsor has signaled a potential revival, but the defeat is a short-term win for protections around medical use and workplace rights.

At the same time, Tennessee regulators reported more than 650 unlicensed sellers of hemp-derived THC. That enforcement sweep shows regulators are tightening the market, which could benefit licensed operators while creating near-term uncertainty for smaller retailers and product suppliers who remain out of compliance.

What to Watch

Here are the catalysts and risks you'll want to monitor over the next few days and weeks as you consider positioning in the sector.

• Virginia governor's decision and implementation timeline, including licensing windows and tax rates that will shape profitability for entrants. A signature could prompt early partner and acquisition activity.
• Georgia's rulemaking and program rollout schedule, particularly how new consumption methods are regulated and which companies qualify to supply products.
• Oklahoma legislative calendar, any attempts to revive workplace-related bills, and how employers respond to the current status quo. This matters for employee-focused risk exposure in multi-state operators.
• Tennessee enforcement: tracking license application backlogs and whether regulators offer amnesty or pursue shutdowns, which could shift retail share toward compliant operators.
• Company-level focus: Ascend Wellness ($AAWH) will be watched for commentary on store growth plans, path to profitability, and any capital allocation moves. Also keep an eye on ETFs and leaders like $MSOS, $TCNNF, $GTBIF, $CURLF, and $TLRY for sector flow signals and relative strength.
• Macro and capital markets: with U.S. stocks closed today, liquidity and news flow when markets reopen Monday could drive sharper moves if any state-level headlines land while markets were closed.

Bottom Line

• Policy momentum in Virginia and Georgia is the headline risk catalyst, creating longer-term growth optionality for regulated operators.
• Oklahoma's rejection of broader employer authority to fire medical users is a regulatory win for patient protections and reduces a near-term legislative headwind.
• Regulatory enforcement in Tennessee underscores that compliance will increasingly separate winners from losers, so favor licensed, well-capitalized operators.
• Ascend Wellness posted solid revenue and margin expansion, but investors should watch the company's path to operating profitability and store rollouts.
• If you're invested in the sector, be selective, focus on regulated operators with clear market access, and be ready for volatility when markets reopen Monday.

FAQ

Q: How likely is Virginia legal sales to start quickly after a governor's sign-off? A: Implementation usually takes months because of licensing and rulemaking, but lawmakers can set expedited timelines; expect a phased rollout.

Q: Will Georgia's medical changes immediately increase sales? A: Changes tend to be gradual; adding qualifying conditions and consumption methods expands potential patient counts, but distribution and supplier approvals will govern near-term sales growth.

Q: Should you buy cannabis ETFs like $MSOS or individual names after these policy wins? A: ETFs offer diversified exposure to policy-driven upside, while select individual operators may deliver greater upside if they have direct market access; your decision should match your risk tolerance and time horizon.